.

LPL - LPL-ROHINI (NATIONAL REFERENCE

LAB)
SECTOR - 18, BLOCK -E ROHINI
DELHI 110085

Name : DUMMY Collected : 6/3/2018 9:37:00AM

Received : 6/3/2018 9:39:05AM
Lab No. : 140222511 Age: 45 Years Gender: Male Reported : 6/3/2018 1:44:56PM
A/c Status : P Ref By : SELF Report Status : Final

Test Name Results Units Bio. Ref. Interval

Swasth Plus Tax Saver Panel 1

LIVER & KIDNEY PANEL, SERUM

(Spectrophotometry, Indirect ISE)
Bilirubin Total 1.18 mg/dL 0.30 - 1.20
Bilirubin Direct 0.25 mg/dL <0.20
Bilirubin Indirect 0.93 mg/dL <1.10
AST (SGOT) 58 U/L <50
ALT (SGPT) 46 U/L <50
GGTP 208 U/L <55
Alkaline Phosphatase (ALP) 107 U/L 30 - 120
Total Protein 7.70 g/dL 6.40 - 8.30
Albumin 4.56 g/dL 3.50 - 5.20
A : G Ratio 1.45 0.90 - 2.00
Urea 10.00 mg/dL 17.00 - 43.00
Creatinine 0.54 mg/dL 0.67 - 1.17
Uric Acid 6.60 mg/dL 3.50 - 7.20
Calcium, Total 9.20 mg/dL 8.80 - 10.60
Phosphorus 3.20 mg/dL 2.40 - 4.40
Sodium 134.00 mEq/L 136.00 - 146.00
Potassium 3.97 mEq/L 3.50 - 5.10
Chloride 98.00 mEq/L 101.00 - 109.00

THYROID PROFILE,TOTAL, SERUM

(CLIA)
T3, Total 1.15 ng/mL 0.60 - 1.81
T4, Total 6.10 ug/dL 5.01 - 12.45
TSH 3.36 uIU/mL 0.35 - 5.50

Note
1. TSH levels are subject to circadian variation, reaching peak levels between 2 - 4.a.m. and at a
minimum between 6-10 pm . The variation is of the order of 50%, hence time of the day has
influence on the measured serum TSH concentrations.
2. Recommended test for T3 and T4 is unbound fraction or free levels as it is metabolically active.
3. Physiological rise in Total T3 / T4 levels is seen in pregnancy and in patients on steroid therapy.

Clinical Use
PatientReportSCSuperPanel.GENERAL_PANEL_ANALYTE_SC (Version: 6)

*140222511* Page 1 of 8
.

LPL - LPL-ROHINI (NATIONAL REFERENCE

LAB)
SECTOR - 18, BLOCK -E ROHINI
DELHI 110085

Name : DUMMY Collected : 6/3/2018 9:37:00AM

Received : 6/3/2018 9:39:05AM
Lab No. : 140222511 Age: 45 Years Gender: Male Reported : 6/3/2018 1:44:56PM
A/c Status : P Ref By : SELF Report Status : Final

Test Name Results Units Bio. Ref. Interval

· Primary Hypothyroidism
· Hyperthyroidism
· Hypothalamic - Pituitary hypothyroidism
· Inappropriate TSH secretion
· Nonthyroidal illness
· Autoimmune thyroid disease
· Pregnancy associated thyroid disorders
· Thyroid dysfunction in infancy and early childhood

PatientReportSCSuperPanel.GENERAL_PANEL_ANALYTE_SC (Version: 6)

*140222511* Page 2 of 8
.

LPL - LPL-ROHINI (NATIONAL REFERENCE

LAB)
SECTOR - 18, BLOCK -E ROHINI
DELHI 110085

Name : DUMMY Collected : 6/3/2018 9:37:00AM

Received : 6/3/2018 9:39:05AM
Lab No. : 140222511 Age: 45 Years Gender: Male Reported : 6/3/2018 1:44:56PM
A/c Status : P Ref By : SELF Report Status : Final

Test Name Results Units Bio. Ref. Interval

URINE EXAMINATION, ROUTINE; URINE, R/E
(Automated Strip Test, Microscopy)

Physical

Colour Light Yellow Pale yellow

Specific Gravity <=1.005 1.001 - 1.030

pH 7 5.0 - 8.0

Chemical

Proteins Nil Nil

Glucose Nil Nil

Ketones Nil Nil

Bilirubin Nil Nil

Urobilinogen Normal Normal

Leucocyte Esterase Negative Negative

Nitrite Negative Negative

Microscopy

R.B.C. Negative Negative

Pus Cells Negative 0-5 WBC / hpf

Epithelial Cells Few Few

Casts Nil Nil /lpf

Crystals Nil Nil

Others Nil -

PatientReportSCSuperPanel.URINE_EXAMINATION_SC (Version: 6)

*140222511* Page 3 of 8
.

LPL - LPL-ROHINI (NATIONAL REFERENCE

LAB)
SECTOR - 18, BLOCK -E ROHINI
DELHI 110085

Name : DUMMY Collected : 6/3/2018 9:37:00AM

Received : 6/3/2018 9:39:05AM
Lab No. : 140222511 Age: 45 Years Gender: Male Reported : 6/3/2018 1:44:56PM
A/c Status : P Ref By : SELF Report Status : Final

Test Name Results Units Bio. Ref. Interval

HbA1c (GLYCOSYLATED HEMOGLOBIN), BLOOD 5.9 %

(HPLC, NGSP certified)

Interpretation
-------------------------------------------------------------------------------
| As per American Diabetes Association (ADA) |
|-------------------------------------------------------------------------------|
| Reference Group | HbA1c in % |
|-------------------------------|-----------------------------------------------|
| Non diabetic adults >=18 years| <5.7 |
|-------------------------------|-----------------------------------------------|
| At risk (Prediabetes) | 5.7 - 6.4 |
|-------------------------------|-----------------------------------------------|
| Diagnosing Diabetes | >= 6.5 |
|-------------------------------|-----------------------------------------------|
| Therapeutic goals for glycemic| Age > 19 years |
| control | . Goal of therapy: < 7.0 |
| | . Action suggested: > 8.0 |
| | |
| | Age < 19 years |
| | . Goal of therapy: <7.5 |
-------------------------------------------------------------------------------

Note: 1. Since HbA1c reflects long term fluctuations in the blood glucose concentration, a
diabetic patient who is recently under good control may still have a high concentration of
HbA1c. Converse is true for a diabetic previously under good control but now poorly
controlled .
2. Target goals of < 7.0 % may be beneficial in patients with short duration of diabetes, long
life expectancy and no significant cardiovascular disease. In patients with significant
complications of diabetes, limited life expectancy or extensive co-morbid conditions,
targeting a goal of < 7.0 % may not be appropriate.

Comments
HbA1c provides an index of average blood glucose levels over the past 8 - 12 weeks and is a much better
indicator of long term glycemic control as compared to blood and urinary glucose determinations.

ADA criteria for correlation between HbA1c & Mean plasma glucose levels
---------------------------------------
| HbA1c(%) | Mean Plasma Glucose (mg/dL)|
|----------|----------------------------|
| 6 | 126 |
|----------|----------------------------|
| 7 | 154 |
|----------|----------------------------|
| 8 | 183 |
|----------|----------------------------|

PatientReportSCSuperPanel.HBELECTRO_SC (Version: 7)

*140222511* Page 4 of 8
.

LPL - LPL-ROHINI (NATIONAL REFERENCE

LAB)
SECTOR - 18, BLOCK -E ROHINI
DELHI 110085

Name : DUMMY Collected : 6/3/2018 9:37:00AM

Received : 6/3/2018 9:39:05AM
Lab No. : 140222511 Age: 45 Years Gender: Male Reported : 6/3/2018 1:44:56PM
A/c Status : P Ref By : SELF Report Status : Final

Test Name Results Units Bio. Ref. Interval

| 9 | 212 |
|----------|----------------------------|
| 10 | 240 |
|----------|----------------------------|
| 11 | 269 |
|----------|----------------------------|
| 12 | 298 |
---------------------------------------

PatientReportSCSuperPanel.HBELECTRO_SC (Version: 7)

*140222511* Page 5 of 8
.

LPL - LPL-ROHINI (NATIONAL REFERENCE

LAB)
SECTOR - 18, BLOCK -E ROHINI
DELHI 110085

Name : DUMMY Collected : 6/3/2018 9:37:00AM

Received : 6/3/2018 9:39:05AM
Lab No. : 140222511 Age: 45 Years Gender: Male Reported : 6/3/2018 1:44:56PM
A/c Status : P Ref By : SELF Report Status : Final

Test Name Results Units Bio. Ref. Interval

HEMOGRAM
(Electrical Impendance & VCS, Capillary photometry,Photometry)

Hemoglobin 17.10 13.00 -g/dL

17.00
Packed Cell Volume (PCV) 50.70 % 40.00 - 50.00
RBC Count 5.29 mill/mm3
4.50 - 5.50
MCV 96.00 80.00 - 100.00fL
MCH 32.30 27.00 - 32.00 pg
MCHC 33.60 g/dL
32.00 - 35.00
Red Cell Distribution Width (RDW) 12.80 % 11.50 - 14.50
Total Leukocyte Count (TLC) 7.20 thou/mm3 4.00 - 10.00
Differential Leucocyte Count (DLC)

Segmented Neutrophils 69.50 % 40.00 - 80.00

Lymphocytes 20.40 % 20.00 - 40.00
Monocytes 8.60 % 2.00 - 10.00
Eosinophils 1.20 % 1.00 - 6.00
Basophils 0.30 % <2.00
Absolute Leucocyte Count

Neutrophils 5.00 thou/mm3 2.00 - 7.00

Lymphocytes 1.47 thou/mm3 1.00 - 3.00
Monocytes 0.62 thou/mm3 0.20 - 1.00
Eosinophils 0.09 thou/mm3 0.02 - 0.50
Basophils 0.02 thou/mm3 0.01 - 0.10
Platelet Count 130.0 thou/mm3
150.00 - 450.00
ESR 9 0 - 15 mm/hr

Note
1. As per the recommendation of International council for Standardization in Hematology, the differential
leucocyte counts are additionally being reported as absolute numbers of each cell in per unit volume of
blood

2. Test conducted on EDTA whole blood

*140222511* Page 6 of 8
.

LPL - LPL-ROHINI (NATIONAL REFERENCE

LAB)
SECTOR - 18, BLOCK -E ROHINI
DELHI 110085

Name : DUMMY Collected : 6/3/2018 9:37:00AM

Received : 6/3/2018 9:39:05AM
Lab No. : 140222511 Age: 45 Years Gender: Male Reported : 6/3/2018 1:44:56PM
A/c Status : P Ref By : SELF Report Status : Final

Test Name Results Units Bio. Ref. Interval

GLUCOSE, FASTING (F), PLASMA 111.00 mg/dL 70.00 - 100.00
(Hexokinase)

LIPID SCREEN, SERUM

(Spectrophotometry)

Cholesterol, Total 158.00 mg/dL <200.00

Triglycerides 189.00 mg/dL <150.00

HDL Cholesterol 54.50 mg/dL >40.00

LDL Cholesterol, Calculated 65.70 mg/dL <100.00

VLDL Cholesterol,Calculated 37.80 mg/dL <30.00

Interpretation

-------------------------------------------------------------
| REMARKS | TOTAL | TRIGLYCERIDE | LDL CHOLESTEROL|
| | CHOLESTEROL| in mg/dL | in mg/dL |
| | in mg/dL | | |
|----------------|------------|--------------|----------------|
| Optimal | <200 | <150 | <100 |
|----------------|------------|--------------|----------------|
| Above Optimal | - | - | 100-129 |
|----------------|------------|--------------|----------------|
| Borderline High| 200-239 | 150-199 | 130-159 |
|----------------|------------|--------------|----------------|
| High | >=240 | 200-499 | 160-189 |
|----------------|------------|--------------|----------------|
| Very High | - | >=500 | >=190 |
-------------------------------------------------------------

Note
1. Measurements in the same patient can show physiological & analytical variations. Three serial
samples 1 week apart are recommended for Total Cholesterol, Triglycerides, HDL & LDL Cholesterol.
2. ATP III recommends a complete lipoprotein profile as the initial test for evaluating cholesterol.
3. Friedewald equation to calculate LDL cholesterol is most accurate when Triglyceride level is < 400
mg/dL. Measurement of Direct LDL cholesterol is recommended when Triglyceride level is > 400
mg/dL.

IRON STUDIES, SERUM

(Spectrophotometry)
PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 7)

*140222511* Page 7 of 8
.

LPL - LPL-ROHINI (NATIONAL REFERENCE

LAB)
SECTOR - 18, BLOCK -E ROHINI
DELHI 110085

Name : DUMMY Collected : 6/3/2018 9:37:00AM

Received : 6/3/2018 9:39:05AM
Lab No. : 140222511 Age: 45 Years Gender: Male Reported : 6/3/2018 1:44:56PM
A/c Status : P Ref By : SELF Report Status : Final

Test Name Results Units Bio. Ref. Interval

Iron 96.00 µg/dL 65.00 - 175.00

Total Iron Binding Capacity 384.00 µg/dL 250.00 - 425.00

Transferrin Saturation 25.00 % 20.00 - 50.00

Comments
Iron is an essential trace mineral element which forms an important component of hemoglobin,
metallocompounds and Vitamin A. Deficiency of iron, leads to microcytic hypochromic anemia. The toxic
effects of iron are deposition of iron in various organs of the body and hemochromatosis.
Total Iron Binding capacity (TIBC) is a direct measure of the protein Transferrin which transports iron from
the gut to storage sites in the bone marrow. In iron deficiency anemia, serum iron is reduced and TIBC
increases.
Transferrin Saturation occurs in Idiopathic hemochromatosis and Transfusional hemosiderosis where no
unsaturated iron binding capacity is available for iron mobilization. Similar condition is seen in congenital
deficiency of Transferrin.

Dr. Anil Arora Dr Biswadip Hazarika Dr Himangshu Mazumdar Dr. Nimmi Kansal
MD (Pathology) MD (Pathology) MD (Biochemistry) MD (Biochemistry)
HOD Hemat & Imm - NRL Sr. Consultant Pathologist - NRL Consultant Biochemist - NRL HOD Biochem & IA - NRL

Dr. Shalabh Malik

MD (Microbiology)
National Head - Microbiology &
Serology - NRL

-------------------------------End of report --------------------------------

PatientReportSCSuperPanel.SP_GENERAL_TEMPLATE01_SC (Version: 7)

*140222511* Page 8 of 8